USA - NYSE:SGFY - US82671G1004 - Common Stock
The current stock price of SGFY is 30.49 USD. In the past month the price increased by 5.9%. In the past year, price increased by 64.81%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.57 | 100.50B | ||
| CI | THE CIGNA GROUP | 9.54 | 72.31B | ||
| LH | LABCORP HOLDINGS INC | 16.93 | 22.26B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.22 | 20.98B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.96 | 19.33B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.74B | ||
| DVA | DAVITA INC | 13.33 | 8.80B | ||
| HIMS | HIMS & HERS HEALTH INC | 66.76 | 8.15B | ||
| CHE | CHEMED CORP | 20.27 | 6.50B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.13 | 5.62B | ||
| RDNT | RADNET INC | 193.32 | 5.65B | ||
| OPCH | OPTION CARE HEALTH INC | 19.35 | 4.68B |
Signify Health, Inc. is a healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. The company is headquartered in Norwalk, Connecticut and currently employs 2,200 full-time employees. The company went IPO on 2021-02-11. The firm is engaged in offering a suite of total cost of care enablement services, including, in-home health evaluations (IHEs) performed either within the patient’s home, virtually or at a healthcare provider facility, diagnostic and preventive services, Accountable Care Organizations (ACO) enablement services, provider enablement services, 340B referrals and return to home services. Through its IHEs, the Company creates a comprehensive, documented record of the clinical, social, and behavioral needs of its health plan customers and seeks to further engage them with the healthcare system. The firm also offers Diagnostic and Preventive Services (DPS) to address care gaps when coupled with an IHE. Through DPS, it offers in-home screenings, including spirometry, peripheral artery and disease screening, among others.
SIGNIFY HEALTH INC -CLASS A
800 Connecticut Avenue
Norwalk CONNECTICUT 06854 US
CEO: Kyle Armbrester
Employees: 2200
Phone: 12035414600.0
Signify Health, Inc. is a healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. The company is headquartered in Norwalk, Connecticut and currently employs 2,200 full-time employees. The company went IPO on 2021-02-11. The firm is engaged in offering a suite of total cost of care enablement services, including, in-home health evaluations (IHEs) performed either within the patient’s home, virtually or at a healthcare provider facility, diagnostic and preventive services, Accountable Care Organizations (ACO) enablement services, provider enablement services, 340B referrals and return to home services. Through its IHEs, the Company creates a comprehensive, documented record of the clinical, social, and behavioral needs of its health plan customers and seeks to further engage them with the healthcare system. The firm also offers Diagnostic and Preventive Services (DPS) to address care gaps when coupled with an IHE. Through DPS, it offers in-home screenings, including spirometry, peripheral artery and disease screening, among others.
The current stock price of SGFY is 30.49 USD. The price increased by 0.07% in the last trading session.
SIGNIFY HEALTH INC -CLASS A (SGFY) has a dividend yield of 1.26%. The yearly dividend amount is currently 0.3.
SGFY has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
SIGNIFY HEALTH INC -CLASS A (SGFY) operates in the Health Care sector and the Health Care Providers & Services industry.
You can find the ownership structure of SIGNIFY HEALTH INC -CLASS A (SGFY) on the Ownership tab.
ChartMill assigns a technical rating of 6 / 10 to SGFY. When comparing the yearly performance of all stocks, SGFY is one of the better performing stocks in the market, outperforming 96.32% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to SGFY. The financial health of SGFY is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months SGFY reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -390.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.53 |
16 analysts have analysed SGFY and the average price target is 30.01 USD. This implies a price decrease of -1.59% is expected in the next year compared to the current price of 30.49.
For the next year, analysts expect an EPS growth of 200.72% and a revenue growth 13.26% for SGFY